Biblio
“How Do Persons with Young and Late Onset Dementia Die?”, J Alzheimers Dis, vol. 81, no. 2, pp. 843-852, 2021.
, “Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.”, Sci Transl Med, vol. 3, no. 89, p. 89ra57, 2011.
, “Human Gut Microbiota in Health and Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 549-560, 2018.
, “Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.”, J Alzheimers Dis, vol. 57, no. 3, pp. 857-871, 2017.
, “Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.”, J Alzheimers Dis, vol. 49, no. 3, pp. 783-95, 2016.
, “Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 82, no. s1, pp. S109-S126, 2021.
, “"I Don't Think Of It As An Illness": Illness Representations in Mild to Moderate Dementia.”, J Alzheimers Dis, vol. 51, no. 1, pp. 139-50, 2016.
, “The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.”, J Alzheimers Dis, vol. 80, no. 2, pp. 865-875, 2021.
, “Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 867-876, 2018.
, “The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1377-1385, 2018.
, “Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 483-494, 2023.
, “Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort.”, J Alzheimers Dis, vol. 85, no. 2, pp. 925-940, 2022.
, “Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 405-15, 2016.
, “Impact of Hearing Aids on Progression of Cognitive Decline, Depression, and Quality of Life Among People with Cognitive Impairment and Dementia.”, J Alzheimers Dis, vol. 92, no. 2, pp. 629-638, 2023.
, “The Impact of Music on the Self in Dementia.”, J Alzheimers Dis, vol. 61, no. 3, pp. 827-841, 2018.
, “Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.”, J Alzheimers Dis, vol. 51, no. 3, pp. 713-25, 2016.
, “Impact of Social Isolation on People with Dementia and Their Family Caregivers.”, J Alzheimers Dis, vol. 81, no. 2, pp. 607-617, 2021.
, “Impact of the MIND Diet on Cognition in Individuals with Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 967-977, 2023.
, “Impacts of High Serum Total Cholesterol Level on Brain Functional Connectivity in Non-Demented Elderly.”, J Alzheimers Dis, vol. 50, no. 2, pp. 455-63, 2016.
, “Impaired Autophagy in APOE4 Astrocytes.”, J Alzheimers Dis, vol. 51, no. 3, pp. 915-27, 2016.
, “Impaired Parahippocampus Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1051-64, 2016.
, “Implementing Delirium Prevention in the Era of COVID-19.”, J Alzheimers Dis, vol. 79, no. 1, pp. 31-36, 2021.
, “Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1735-1745, 2021.
, “In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
, “The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 809-18, 2016.
,